Volitionrx Ltd (VNRX) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Volitionrx Ltd
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
NYSE · Manufacturing
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.
No intraday reading yet this session.
No peer readings for Volitionrx Ltd yet.
No case yet. It builds on the next filing, report or 13F period.
tall tick = annual report · 1 on record
24 managers report a position worth $2.6M between them, and 2 of them hold 80% of it.
VNRX (Volitionrx Ltd) has 0 disclosed suppliers and 9 disclosed customers, strongest disclosure first.
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.